Dapagliflozin improves behavioral dysfunction of Huntington's disease in rats via inhibiting apoptosis-related glycolysis

Citation:
Yamany, M. E. - F., A. E. El-Sahar, A. A. Rastanawi, and M. A. Saad, "Dapagliflozin improves behavioral dysfunction of Huntington's disease in rats via inhibiting apoptosis-related glycolysis", Life Sciences, vol. 257, pp. 118076, 2020.
PreviewAttachmentSize
dapagliflozin_improves_behavioral_dysfunction_of_huntingtons_disease_in_rats_via_inhibiting_apoptosis-related_glycolysis.pdf1.63 MB
Tourism